<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p>Diabetic ketoacidosis (DKA) is a condition associated with high blood glucose (usually &gt; 18 mmol/L), which nonetheless, is unavailable to the body tissues as a source of energy. Fat is therefore broken down as an alternative source of energy, releasing toxic chemicals called ketones as a by-product. Additionally, there is severe dehydration and electrolyte imbalance in DKA, especially low potassium. It is a common cause of death among diabetes patients in Ghana. It often occurs in type 1 diabetes patients but may also occur in type 2 diabetes.</p><p>In contrast, the Hyperosmolar Non-Ketotic state (HONK) in diabetes occurs primarily in Type 2 patients, and is similar in its clinical presentation to diabetic ketoacidosis in many respects. A major difference, however, is the absence of a significant amount of ketones in the urine (usually trace or 1+) and the presence of severe dehydration. The management of this condition is similar to that of DKA.</p><p><strong>CAUSES</strong></p><ul><li>Severe deficiency of insulin</li><li>Interruption of anti-hyperglycaemic therapy (usually for financial reasons or for alternative treatment)</li><li>Stress of intercurrent illness (e.g. infection, myocardial infarction,</li><li>stroke, surgery, complicated pregnancy etc.)</li></ul><p><strong>SYMPTOMS</strong></p><ul><li>Polyuria</li><li>Polydipsia</li><li>Nausea, vomiting</li><li>Abdominal pain</li><li>Alteration in sensorium or collapse</li><li>Symptoms of infection or other underlying condition</li></ul><p><strong>SIGNS</strong></p><ul><li>Dehydration (dry skin, reduced skin turgor or sunken eyes)</li><li>Deep and fast breathing</li><li>Low blood pressure</li><li>Fast and weak pulse</li><li>'Fruity' breath (smell of acetone)</li><li>Confusion, stupor or unconsciousness</li><li>Evidence of infection, recent surgery, stroke etc.</li></ul><p><strong>INVESTIGATIONS</strong></p><ul><li>Random blood glucose (usually &gt;18 mmol/L)</li><li>Urine glucose (usually &gt;3+)</li><li>Urine ketones (usually &gt;2+)</li><li>Blood urea and electrolytes (usually low potassium, however if in renal failure urea and potassium may be high)</li><li>Blood film for malaria parasites</li><li>Full blood count (raised white cell count would suggest bacterial infection)</li><li>Urine culture</li><li>Blood culture</li><li>Chest X-ray (for pneumonia)</li><li>Arterial blood gases</li><li>Electrocardiogram (to identify hypokalaemia, and in adult patients to exclude acute myocardial infarction as a precipitating factor)</li></ul><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To replace the fluid losses</li><li>To replace the electrolyte losses, especially potassium</li><li>To replace deficient insulin</li><li>To seek the underlying cause and treat appropriately</li></ul><p><strong>Pharmacological treatment</strong></p><p><strong>A. Management of Diabetic Ketoacidosis (DKA)<br><br>Table 12-1: Regime for managing Diabetic Ketoacidosis in Adults</strong></p>
    <div style="width: 95vw;">
        <img src="https://osamfrimpong.github.io/stg_app_web/images/dka_in_adults.jpg" alt="DKA in Adults" style="max-width: 100%;height: auto;margin: auto;">
        </div>
        <div style="width: 95vw;">
            <img src="https://osamfrimpong.github.io/stg_app_web/images/dka_in_children.jpg" alt="DKA in Children" style="max-width: 100%;height: auto;margin: auto;">
            </div>
    <p> </p><p> </p><div class="table"><table><tbody><tr><td colspan="6"><strong>Table 12-2: Regime for managing Diabetic Ketoacidosis in Children</strong></td></tr><tr><td rowspan="2">CHILDREN</td><td rowspan="3"><p> </p><p>Blood Glucose &amp; Urine Ketone</p><p>Test Results</p></td><td colspan="2">Intravenous Fluids</td><td rowspan="3">Soluble/ Regular Insulin</td><td rowspan="3">Potassium Chloride (KCl) Infusion</td></tr><tr><td rowspan="2">Type of Fluid</td><td rowspan="2">Rate of IV Fluid Infusion</td></tr><tr><td><p>Initiating Management</p><p> </p></td></tr><tr><td><p>Monitor blood</p><p>glucose hourly</p><p> </p><p>Monitor urine ketones twice daily</p><p> </p><p> </p></td><td><p>Blood glucose</p><p>&gt;18 mmol/L 0r</p><p>Urine ketones</p><p>&gt;2+</p></td><td>Sodium Chloride 0.9%</td><td><p>1st hour 15 ml/kg</p><p> </p><p>2nd hour 15 ml/kg</p><p>3rd Hour</p><p>7.5 ml/kg</p><p> </p><p>4th hour and subsequently, adjust fluid rate to meet requirements</p></td><td><p>Soluble/ regular insulin, IV or IM, 0.15 unit/ kg stat</p><p> </p><p>Thereafter, administer Soluble/regular insulin, IV Infusion or IM</p><p>0.1 units/kg hourly until Blood glucose</p><p>&lt; 11 mmol/L</p></td><td><p>Start 2 hours after initiating insulin and Sodium Chloride Infusion</p><p> </p><p>Check adequate urine output (&gt;30 ml/hour)</p><p> </p><p>Add KCl 0.2</p><p>-0.4 mmol/</p><p>kg (max. 10 mmol) in IV fluids. Run infusion over at least one hour</p></td></tr><tr><td colspan="6">Maintaining Management</td></tr><tr><td><p>Monitor blood glucose every 4 Hours</p><p> </p><p>Monitor urine ketones twice daily</p><p> </p><p> </p></td><td><p>Blood glucose</p><p>&lt; 13 mmol/L</p></td><td><p>Sodium Chloride in 4.3%</p><p>Glucose</p><p> </p><p>This measure is necessary to prevent subsequent hypoglycaemia</p></td><td>Set Infusion rate to meet requirements</td><td>Soluble/ regular insulin subcutaneously by 'sliding scale' (see example of 'sliding scale' in the table below)</td><td><p>Repeat Potassium Infusion after</p><p>2 hours if necessary</p><p> </p><p>Check blood Potassium level twice Daily</p><p> </p><p>Withhold KCl if blood level of potassium</p><p>&gt;6 mmol/L</p></td></tr><tr><td colspan="6">Regular Management</td></tr><tr><td>Monitor blood glucose twice daily (pre-breakfast and pre-supper)</td><td><p>Blood glucose maintained between 6 -11 mmol/L</p><p>Urine ketones negative or trace</p></td><td colspan="2">Patient eating normally (recommended diet)</td><td>Change from 'sliding scale' to twice daily subcutaneous intermediate- acting or premixed insulin</td><td>Potassium chloride, oral, if required</td></tr></tbody></table></div><p> </p><div class="table"><table><tbody><tr><td colspan="3"><strong>Box 12-2: Sample Sliding Scale Chart</strong></td></tr><tr><td>Blood Glucose Result (following 4-hourly testing)</td><td colspan="2">Corresponding Dose of Regular Insulin to administer Subcutaneously</td></tr><tr><td>mmol/L</td><td>ADULTS</td><td>CHILDREN</td></tr><tr><td>&lt; 6.0</td><td>No Insulin</td><td>No Insulin</td></tr><tr><td>6.1 - 9.0</td><td>4 units</td><td>0.06 units/kg</td></tr><tr><td>9.1 - 12.0</td><td>6 units</td><td>0.09 units/kg</td></tr><tr><td>12.1 - 15.0</td><td>8 units</td><td>0.12 units/kg</td></tr><tr><td>15.1 - 18.0</td><td>10 units</td><td><ol><li>units/kg</li></ol></td></tr></tbody></table></div><p> </p><div class="table"><table><tbody><tr><td><strong>Note 12-4</strong></td></tr><tr><td><p>The example of the sliding scale given above is not a fixed standard. The requirement of insulin for each level of blood glucose measured differs from patient to patient. The corresponding insulin doses may therefore need to be adjusted up or down to suit each patient.</p><p>For both adults and children, continue the sliding scale, making appropriate adjustments to the doses of insulin, until the patient is eating normally and the urine is free of ketones before changing to twice-daily intermediate or premixed insulin. This may take on average 12-72 hours.</p></td></tr></tbody></table></div><p><strong>B. Management of Hyperosmolar Non-Ketotic state (HONK)</strong></p><p>(See 'Management of DKA' above)</p><p><strong>C. Adjunct Treatment for DKA and HONK</strong></p><ul><li>Broad-spectrum antibiotics for suspected infections (See appropriate section)</li><li>Treat malaria if suspected or confirmed (See appropriate section)</li></ul><p><strong>REFERRAL CRITERIA</strong></p><p>If there are inadequate resources for managing the patient, start 0.9% Sodium Chloride, IV, and give initial dose of soluble or regular insulin IV or IM after confirming blood glucose and urine ketone levels and refer to a nearby regional or teaching hospital.</p><p>If the patient remains comatose or fails to pass adequate amounts of urine despite management, refer to a regional or teaching hospital for further care.</p>
</body>
</html>
